Get informed when a big investor buys or sells
+ FollowOvervalued by 38.4% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $1.36 Billion |
|---|---|
| Enterprise Value | $1.54 Billion |
| Earnings per Share | $0.67 |
| Beta | 1.17 |
| Outstanding Shares | 12,436,900 |
| P/E Ratio | 90.83 |
|---|---|
| PEG | -20.04 |
| Price to Sales | 2.67 |
| Price to Book Ratio | 5.23 |
| Enterprise Value to Revenue | 2.83 |
| Enterprise Value to EBIT | 89.63 |
| Enterprise Value to Net Income | 106 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.74 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticat...